Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations

Metabolism: Clinical and Experimental

Volumn 60, Issue 9, 2011, Pages 1294-1299

  Kim, Seon Mee ^a,b   Cho, Geum Joo ^c   Yannakoulia, Mary ^b,d   Hwang, Taik Gun ^c   Kim, In Hee ^c   Park, Eun Kyung ^c   Mantzoros, Christos S ^b  

^a Korea University College of Medicine   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Guro Gu Public Health Centre   (South Korea)

^d HAROKOPIO UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; VASPIN;

ALCOHOL ABSTINENCE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; FEMALE; HEALTH CENTER; HUMAN; INSULIN RESISTANCE; KOREA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUTRITIONAL COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING CESSATION;

ADIPONECTIN; AGED; FEMALE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SERPINS;

EID: 80051787356     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.01.013     Document Type: Article

References (47)

1. Pi-Sunyer X. The metabolic syndrome: how to approach differing definitions Med Clin North Am 91 2007 1025 1040 vii (Pubitemid 47625436)
2. Magkos F., Yannakoulia M., and Chan J.L. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification Annu Rev Nutr 29 2009 223 256
3. Christ M., Iannello C., and Iannello P.G. Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome Int J Cardiol 97 2004 115 122 (Pubitemid 39178532)
4. Villareal D.T., Miller B.V. III, and Banks M. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults Am J Clin Nutr 84 2006 1317 1323 (Pubitemid 44912812)
5. Muzio F., Mondazzi L., and Sommariva D. Long-term effects of low-calorie diet on the metabolic syndrome in obese nondiabetic patients Diabetes Care 28 2005 1485 1486 (Pubitemid 40756718)
6. Case C.C., Jones P.H., and Nelson K. Impact of weight loss on the metabolic syndrome Diabetes Obes Metab 4 2002 407 414 (Pubitemid 35345455)
7. Kukkonen-Harjula K.T., Borg P.T., and Nenonen A.M. Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men Prev Med 41 2005 784 790 (Pubitemid 41400045)
8. Phelan S., Wadden T.A., and Berkowitz R.I. Impact of weight loss on the metabolic syndrome Int J Obes (Lond) 31 2007 1442 1448 (Pubitemid 47339915)
9. Appel L.J., Sacks F.M., and Carey V.J. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial JAMA 294 2005 2455 2464 (Pubitemid 41627923)
10. Kris-Etherton P.M., Pearson T.A., and Wan Y. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations Am J Clin Nutr 70 1999 1009 1015
11. Spranger J., Kroke A., and Mohlig M. Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228 (Pubitemid 36126226)
12. Daimon M., Oizumi T., and Saitoh T. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study Diabetes Care 26 2003 2015 2020 (Pubitemid 41184244)
13. Stefan N., Vozarova B., and Funahashi T. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans Diabetes 51 2002 1884 1888 (Pubitemid 34564302)
14. Mantzoros C.S., Li T., and Manson J.E. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes J Clin Endocrinol Metab 90 2005 4542 4548 (Pubitemid 41159340)
15. Shetty G.K., Economides P.A., and Horton E.S. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2450 2457 (Pubitemid 39281400)
16. Rokling-Andersen M.H., Reseland J.E., and Veierod M.B. Effects of long-term exercise and diet intervention on plasma adipokine concentrations Am J Clin Nutr 86 2007 1293 1301 (Pubitemid 350126230)
17. Mather K.J., Funahashi T., and Matsuzawa Y. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program Diabetes 57 2008 980 986
18. Balagopal P., George D., and Yarandi H. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents J Clin Endocrinol Metab 90 2005 6192 6197 (Pubitemid 41606543)
19. Cambuli V.M., Musiu M.C., and Incani M. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children J Clin Endocrinol Metab 93 2008 3051 3057
20. Hida K., Wada J., and Eguchi J. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity Proc Natl Acad Sci U S A 102 2005 10610 10615 (Pubitemid 41061602)
21. Kloting N., Berndt J., and Kralisch S. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes Biochem Biophys Res Commun 339 2006 430 436 (Pubitemid 41697566)
22. Gulcelik N.E., Karakaya J., and Gedik A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications Eur J Endocrinol 160 2009 65 70
23. Youn B.S., Kloting N., and Kratzsch J. Serum vaspin concentrations in human obesity and type 2 diabetes Diabetes 57 2008 372 377
24. von Loeffelholz C., Mohlig M., and Arafat A.M. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans Eur J Endocrinol 162 2010 507 513
25. El-Mesallamy H.O., Kassem D.H., and El-Demerdash E. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus Metabolism 60 2011 63 70
26. Chang H.M., Park H.S., and Park C.Y. Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects Metabolism 59 2010 1276 1281
27. Stepan H., Kralisch S., and Klostermann K. Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia Metabolism 59 2010 1054 1056
28. Cakal E., Ustun Y., and Engin-Ustun Y. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome Gynecol Endocrinol 2010 Jul 13 [Epub ahead of print]
29. Handisurya A., Riedl M., and Vila G. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss Obes Surg 20 2010 198 203
30. Chang H.M., Lee H.J., and Park H.S. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance Obesity (Silver Spring) 18 2010 2105 2110
31. Lee M.K., Jekal Y., and Im J.A. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification Clin Chim Acta 411 2010 381 385
32. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
33. Lee S.Y., Park H.S., and Kim D.J. Appropriate waist circumference cutoff points for central obesity in Korean adults Diabetes Res Clin Pract 75 2007 72 80 (Pubitemid 44856015)
34. Yoo H.J., Park M.S., and Kim T.N. A ubiquitous chronic disease care system using cellular phones and the internet Diabet Med 26 2009 628 635
35. Matthews D.R., Hosker J.P., and Rudenski A.S. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
36. Chan D.C., Watts G.F., and Ng T.W. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome Eur J Clin Invest 38 2008 743 751
37. Pasarica M., Tchoukalova Y.D., and Heilbronn L.K. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes Obesity (Silver Spring) 17 2009 1976 1978
38. Storti K.L., Brach J.S., and FitzGerald S.J. Relationships among body composition measures in community-dwelling older women Obesity (Silver Spring) 14 2006 244 251 (Pubitemid 46214754)
39. Sierksma A., Patel H., and Ouchi N. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity Diabetes Care 27 2004 184 189 (Pubitemid 38196730)
40. Qi L., Rimm E., and Liu S. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men Diabetes Care 28 2005 1022 1028 (Pubitemid 40616607)
41. Yannakoulia M., Yiannakouris N., and Melistas L. Dietary factors associated with plasma high molecular and total adiponectin levels in apparently healthy women Eur J Endocrinol 159 2008 R5 R10
42. Fargnoli J.L., Fung T.T., and Olenczuk D.M. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study Am J Clin Nutr 88 2008 1213 1224
43. Mantzoros C.S., Williams C.J., and Manson J.E. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women Am J Clin Nutr 84 2006 328 335 (Pubitemid 44699141)
44. Seeger J., Ziegelmeier M., and Bachmann A. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters J Clin Endocrinol Metab 93 2008 247 251
45. Nguyen Q.M., Srinivasan S.R., and Xu J.H. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study Diabetes Care 31 2008 2044 2049
46. Mente A., Razak F., and Blankenberg S. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance Diabetes Care 33 2010 1629 1634
47. Kaplan R.C., Ho G.Y., and Xue X. Within-individual stability of obesity-related biomarkers among women Cancer Epidemiol Biomarkers Prev 16 2007 1291 1293 (Pubitemid 46984974)